Sandrine Guillard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sandrine Guillard

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Experimental Medicine|June 27, 2012

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screeningAntonio DiGiandomenico, Paul Warrener, Melissa Hamilton, et al.

Oncotarget|September 15, 2016

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapyGeoffrey S Williams, Bina Mistry, Sandrine Guillard, et al.

Cancer Research|June 19, 2007

Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinasesFlorence I Raynaud, Suzanne Eccles, Paul A Clarke, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Experimental Medicine|June 27, 2012

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screeningAntonio DiGiandomenico, Paul Warrener, Melissa Hamilton, et al.

Oncotarget|September 15, 2016

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapyGeoffrey S Williams, Bina Mistry, Sandrine Guillard, et al.

Cancer Research|June 19, 2007

Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinasesFlorence I Raynaud, Suzanne Eccles, Paul A Clarke, et al.

Pageof 2